LeafNLP Demos
Back to explore

Report #2886428

Received Feb 23, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
Dec 7, 2021
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (3)

HeadacheNauseaRash

Symptom narrative

skin rashes/eruption of skin; nausea; headache; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of rash in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. Additional patient notes included patient past medical history and concurrent condition were not reported. On an unknown date, the patient received Shingrix. On 07-DEC-2021, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: skin rashes/eruption of skin), nausea (Verbatim: nausea) and headache (Verbatim: headache). The outcome of the rash, nausea and headache were not reported. It was unknown if the reporter considered the rash, nausea and headache to be related to Shingrix. It was unknown if the company considered the rash, nausea and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 13-FEB-2026 The batch number was not provided and unable to contact the reporter.

Medical history

Comments: patient past medical history and concurrent condition were not reported